Literature DB >> 4572345

Antithymocyte globulin in renal transplant krecipients. A clinical trial.

J G Turcotte, N J Feduska, R F Haines, D T Freier, P W Gikas, F D McDonald, A G Johnson, R M Morrell, N W Thompson.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4572345     DOI： 10.1001/archsurg.1973.01350160102016

Source DB:  PubMed          Journal:  Arch Surg        ISSN： 0004-0010


× No keyword cloud information.
  4 in total

1.  Clinical immunosuppression with antilymphocyte globulin.

Authors:  C R Stiller
Journal:  Can Med Assoc J       Date:  1976-12-18       Impact factor: 8.262

2.  100 sibling kidney transplants followed 2 to 7 1/2 years: a multifactorial analysis.

Authors:  R L Simmons; E J Van Hook; E J Yunis; H Noreen; C M Kjellstrand; R M Condie; S M Mauer; T J Buselmeier; J S Najarian
Journal:  Ann Surg       Date:  1977-02       Impact factor: 12.969

3.  Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors.

Authors:  J S Najarian; R L Simmons; R M Condie; E J Thompson; D S Fryd; R J Howard; A J Matas; D E Sutherland; R M Ferguson; J R Schmidtke
Journal:  Ann Surg       Date:  1976-09       Impact factor: 12.969

4.  The effect of serum ALG concentrations on results following renal transplantation.

Authors:  R J Howard; R M Condie; D E Sutherland; R L Simmons; J S Najarian
Journal:  Ann Surg       Date:  1977-11       Impact factor: 12.969
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.